Efficacy of statins in patients with diabetic nephropathy: a meta-analysis of randomized controlled trials (Q28068027)

Zhongwen Zhang

2

1 reference

Xiaoqian Zhang

3

1 reference

Junyu Zhao

4

1 reference

Xiaojun Zhou

5

1 reference

Qinglei Xu

6

1 reference

Hongxia Shang

7

1 reference

Jianjun Dong

8

1 reference

Lin Liao

9

1 reference

Lipids in Health and Disease

language of work or name

1 reference

12 October 2016

12 references

13 March 2019

14 March 2019

24 March 2019

2 October 2019

29 May 2020

3 July 2020

21 July 2020

31 August 2020

26 January 2021

30 January 2021

4 February 2021

11 references

13 March 2019

14 March 2019

24 March 2019

2 October 2019

29 May 2020

3 July 2020

21 July 2020

31 August 2020

26 January 2021

30 January 2021

4 February 2021

15

1 reference

issue

1

1 reference

page(s)

179

1 reference

Creative Commons Attribution 4.0 International

copyright license

10 references

13 March 2019

14 March 2019

24 March 2019

2 October 2019

3 July 2020

21 July 2020

31 August 2020

26 January 2021

30 January 2021

on focus list of Wikimedia project

4 February 2021

copyright status

copyrighted

0 references

ScienceSource

0 references

cites work

Effect of Statins on Kidney Disease Outcomes: A Systematic Review and Meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5062823

Differential urinary glycoproteome analysis of type 2 diabetic nephropathy using 2D-LC-MS/MS and iTRAQ quantification

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5062823

Current Updates on Therapeutic Advances in the Management of Cardiovascular Diseases

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5062823

The Effects of Simvastatin on Proteinuria and Renal Function in Patients with Chronic Kidney Disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5062823

Effects of Statins on Renal Outcome in Chronic Kidney Disease Patients: A Systematic Review and Meta-Analysis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5062823

Meta-analysis of the effect of statins on renal function

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5062823

The global implications of diabetes and cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5062823

Effect of statin therapy on cardiovascular and renal outcomes in patients with chronic kidney disease: a systematic review and meta-analysis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5062823

Do we need to consider inflammatory markers when we treat atherosclerotic disease?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5062823

Meta-analysis: the effect of statins on albuminuria

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5062823

Statins for improving renal outcomes: a meta-analysis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5062823

How to fully protect the kidney in a severe model of progressive nephropathy: a multidrug approach

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5062823

Diabetic nephropathy: the central role of renal proximal tubular cells in tubulointerstitial injury

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5062823

The role of lipids in renal disease: future challenges.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5062823

Effects of lipids on the pathogenesis of progressive renal failure: role of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in the prevention of glomerulosclerosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5062823

Prognostic indicators in patients presenting with the nephrotic syndrome.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5062823

Effect of pravastatin on loss of renal function in people with moderate chronic renal insufficiency and cardiovascular disease

2 June 2018

1 reference

https://api.crossref.org/works/10.1186/S12944-016-0350-0

Effect of lipid reduction on the progression of renal disease: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/S12944-016-0350-0

Effects of atorvastatin on kidney outcomes and cardiovascular disease in patients with diabetes: an analysis from the Collaborative Atorvastatin Diabetes Study (CARDS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/S12944-016-0350-0

Atorvastatin improves metabolic control and endothelial function in type 2 diabetic patients: a placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/S12944-016-0350-0

Lipid modulation in insulin-dependent diabetes mellitus: effect on microvascular outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/S12944-016-0350-0

Effect of pitavastatin on urinary liver-type fatty acid-binding protein levels in patients with early diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/S12944-016-0350-0

Effect of cerivastatin on urinary albumin excretion and plasma endothelin-1 concentrations in type 2 diabetes patients with microalbuminuria and dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/S12944-016-0350-0

Atorvastatin prevents glomerulosclerosis and renal endothelial dysfunction in hypercholesterolaemic rabbits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/S12944-016-0350-0

A meta-analysis of the role of statins on renal outcomes in patients with chronic kidney disease. Is the duration of therapy important?

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/S12944-016-0350-0

Effect of rosuvastatin on C-reactive protein and renal function in patients with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/S12944-016-0350-0

Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with coronary heart disease and metabolic syndrome: a subgroup analysis of the GREek Atorvastatin and Coronary heart disease Ev

21 January 2018

1 reference

12 December 2020

Renal function and insulin sensitivity during simvastatin treatment in type 2 (non-insulin-dependent) diabetic patients with microalbuminuria

1 reference

12 December 2020

Reduction of Albumin Excretion Rate in Normotensive Microalbuminuric Type 2 Diabetic Patients During Long-Term Simvastatin Treatment

1 reference

12 December 2020

Cholesterol-lowering therapy may retard the progression of diabetic nephropathy

1 reference

12 December 2020

Effects of Lipid-Lowering Therapy with Rosuvastatin on Kidney Function and Oxidative Stress in Patients with Diabetic Nephropathy

1 reference

12 December 2020

Effects of pravastatin on lipid levels, in vitro oxidizability of non-HDL lipoproteins and microalbuminuria in IDDM patients

1 reference

12 December 2020

Plasma lipoproteins and renal function during simvastatin treatment in diabetic nephropathy

1 reference

12 December 2020

Renoprotective effect of atorvastatin on STZ-diabetic rats through attenuating kidney-associated dysmetabolism

1 reference

12 December 2020

10.1186/S12944-016-0350-0

Identifiers

DOI

1 reference

Dimensions Publication ID

1001169306

0 references

1 reference

1 reference

PubMed publication ID

27733168

1 reference